
The UK’s FCA needs more experience with crypto in order to understand the asset class fully, an expert has warned.
Mark Aruliah, senior policy adviser at blockchain analysis firm Elliptic, who spent a number of years as a technical specialist at the FCA, said he doesn’t see any strong advantages in being in the UK as a crypto firm.
“I’m not saying the UK regulator is in a positive or negative position, I think the jury is out for me,” he said.
Speaking at the recent International Financial Services Forum, Aruliah said he was a supporter of strong regulation and investor protection, but it has to include common sense and pragmatism.
“[There needs to be] more experience within the regulator itself to understand what crypto is,” he said.
He added that the regulation of crypto is different to tradition finance, and on top of that there’s tensions between the legislator, politicians looking at crypto as a benefit to jobs and economic growth, and the natural tendency of the FCA to regulate to a high standard.
The main problem is a lack of dialogue between regulators and crypto firms, he said, which happens in traditional securities markets in the UK but not in crypto.
“That’s the bit that has to change if you want to be conducive to a vibrant sector,” he said.
While cryptocurrencies aren’t regulated as an investment, the asset class was brought under money laundering regulations in 2020 which means certain cryptoasset firms must be registered with the FCA before conducting business.
This pushed the FCA’s fees up by £8mn last year, which the regulator said would go towards the costs of developing IT systems and recruiting extra staff for the project.
Featured News
House Budget Bill’s Moratorium on State AI Laws Could Undo A Range of Tech Regs, Critics Say
May 14, 2025 by
CPI
Microsoft Nears EU Antitrust Resolution Over Teams Bundling, Sources Say
May 14, 2025 by
CPI
CMA Investigates Aviva’s £3.6B Acquisition of Direct Line Group
May 14, 2025 by
CPI
Google Urges Texas Judge to Disregard Virginia Antitrust Ruling
May 14, 2025 by
CPI
Anthropic Ordered to Respond After AI Allegedly Fabricates Citation in Legal Filing
May 14, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas